Approximately 15 million people worldwide suffer a stroke each year.1 There is compelling evidence that improved patient outcomes are achieved through early intervention in acute stroke care including thrombolysis, endovascular clot retrieval2 and access to specialised in-patient stroke units. Hyperglycaemia, swallowing dysfunction and elevated temperature are physiological variables known to be associated with poorer stroke outcomes. Optimal management of fever, hyperglycaemia and dysphagia have been identified in international guidelines as priorities for inpatient stroke management.
The Quality in Acute Stroke Care (QASC) Trial, has shown in the countries where the study was conducted that multidisciplinary, nurse-led interventions to manage fever, hyperglycaemia and swallow difficulties following acute stroke significantly improved health outcomes. Results showed that supported implementation of the Fever, Sugar, Swallow (FeSS) Clinical Protocols resulted in 16% decreased death and dependency at 90-days, and in-hospital: reduced mean temperatures, reduced mean glucose levels and improved swallow screening management. There also was a non-significant reduction in length of stay by two days. Results were fast-tracked for publication in The Lancet, with a commentary, winning the Canadian Stroke Congress Award for Impact in 2011 and the 2012 American Heart Association Council on Cardiovascular Nursing Stroke Article of the year.
The Italian study was conducted at the San Camillo Forlanini Hospital in Rome, which is an important hub of the regional Stroke network.
In the first phase, we proceeded to audit the medical records of (n ° 42) patients hospitalized from June to August 2018 with diagnoses of ICD 10 acceptance. For cases at provisional intervals (six months) we will proceed to a new audit titled “Clinical i results of the treatment processes”, and we will verify the implementation of the protocol via body temperature measurements every four to six hours for the first 72 hours, along with eventual treatment. Blood glucose measurements will be taken every four to six hours in the first 72 hours, and possible treatment steps will commence. Evaluation of swallowing ability in the first 24 hours from admission will be assessed, and logopedic advice will be given, as appropriate. The aim of the study is to compare the data obtained with the literature (16 percent reduction in deaths, reduction in hospitalization days [2 days], longer-term survival > 20 percent).
It was found that the detection of temperature and blood sugar in the first 72 hours after admission is made occasionally, while great attention is paid to the detection of swallowing disorders secondary to stroke.
Discussion and Conclusions
The first results confirmed the importance of this treatment’s role in the management of this pathology in reducing complications and increasing benefits to stroke victims in Italy.